Luis Augusto Rohde

Luis Augusto Rohde

Auto-generated profile, based on publicly available information

Luis Augusto Rohde

Universidade Federal do Rio Grande do Sul

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in The Lancet
Verified
Journal Article
Closed access
CKChristian Kieling
Christian Kieling
HBHelen Baker-Henningham
Helen Baker-Henningham
MBMyron Belfer
Myron Belfer
GCGabriella Conti
Gabriella Conti
IEIlgi Ertem
Ilgi Ertem
ARAtif Rahman
Atif Rahman

24 January 2014 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
GPGuilherme V Polanczyk
Guilherme V Polanczyk
EWErik G Willcutt
Erik G Willcutt
GSGiovanni A Salum
Giovanni A Salum
CKChristian Kieling
Christian Kieling
LRLuis A Rohde
Luis A Rohde
Background: Previous studies have identified significant variability in attention-deficit / hyperactivity disorder (ADHD) prevalence estimates worldwide, largely explained by methodological procedures. However, increasing rates of ADHD diagnosis and treatment throughout the past few decades have fuelled concerns about whether the true prevalence of the disorder has increased over time. Methods: We updated the two most comprehensive systematic reviews on ADHD prevalence available in the literature. Meta-regression analyses were conducted to test the effect of year of study in the context of both methodological variables that determined variability in ADHD prevalence (diagnostic criteria, impairment criterion and source of information), and the geographical location of studies. Results: We identified 154 original studies and included 135 in the multivariate analysis. Methodological procedures investigated were significantly associated with heterogeneity of studies. Geographical location and year of study were not associated with variability in ADHD prevalence estimates. Conclusions: Confirming previous findings, variability in ADHD prevalence estimates is mostly explained by methodological characteristics of the studies. In the past three decades, there has been no evidence to suggest an increase in the number of children in the community who meet criteria for ADHD when standardized diagnostic procedures are followed.

1 November 2012 in Journal of Abnormal Psychology
Verified
Journal Article
Closed access
EWErik G. Willcutt
Erik G. Willcutt
JNJoel T. Nigg
Joel T. Nigg
BPBruce F. Pennington
Bruce F. Pennington
MSMary V. Solanto
Mary V. Solanto
LRLuis A. Rohde
Luis A. Rohde
BLBenjamin B. Lahey
Benjamin B. Lahey
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria for attention deficit/hyperactivity disorder (ADHD) specify two dimensions of inattention and hyperactivity-impulsivity symptoms that are used to define three nominal subtypes: predominantly hyperactive-impulsive type (ADHD-H), predominantly inattentive type (ADHD-I), and combined type (ADHD-C). To aid decision making for DSM-5 and other future diagnostic systems, a comprehensive literature review and meta-analysis of 546 studies was completed to evaluate the validity of the DSM-IV model of ADHD. Results indicated that DSM-IV criteria identify individuals with significant and persistent impairment in social, academic, occupational, and adaptive functioning when intelligence, demographic factors, and concurrent psychopathology are controlled. Available data overwhelmingly support the concurrent, predictive, and discriminant validity of the distinction between inattention and hyperactivity-impulsivity symptoms, and indicate that nearly all differences among the nominal subtypes are consistent with the relative levels of inattention and hyperactivity-impulsivity symptoms that define the subtypes. In contrast, the DSM-IV subtype model is compromised by weak evidence for the validity of ADHD-H after first grade, minimal support for the distinction between ADHD-I and ADHD-C in studies of etiological influences, academic and cognitive functioning, and treatment response, and the marked longitudinal instability of all three subtypes. Overall, we conclude that the DSM-IV ADHD subtypes provide a convenient clinical shorthand to describe the functional and behavioral correlates of current levels of inattention and hyperactivity-impulsivity symptoms, but do not identify discrete subgroups with sufficient long-term stability to justify the classification of distinct forms of the disorder. Empirical support is stronger for an alternative model that would replace the subtypes with dimensional modifiers that reflect the number of inattention and hyperactivity-impulsivity symptoms at the time of assessment. (PsycINFO Database Record (c) 2012 APA, all rights reserved).

1 July 2007 in Current Opinion in Psychiatry
Verified
Journal Article
Closed access
GPGuilherme Polanczyk
Guilherme Polanczyk
LRLuis Augusto Rohde
Luis Augusto Rohde
Prevalence estimates of the attention-deficit hyperactivity disorder (ADHD) and the rate of persistence of symptoms across the lifespan are heterogeneous, raising questions about the validity of the diagnosis. This review aims to discuss potential reasons for variability in ADHD prevalence estimates and rates of symptom persistence, as well as to present ADHD prevalence rates during the lifespan. The best available estimates of ADHD prevalence are around 5.29% for children and adolescents and 4.4% in adulthood. Estimates of ADHD prevalence and rate of symptom persistence over time seem to be highly affected by methodological characteristics of the studies. The review of ADHD epidemiology highlights the need for standardizing study methodologies to make findings comparable. Even so, epidemiological cross-national data seem to support the validity of ADHD.

1 July 2016 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
ACArthur Caye
Arthur Caye
TRThiago Botter-Maio Rocha
Thiago Botter-Maio Rocha
LALuciana Anselmi
Luciana Anselmi
JMJoseph Murray
Joseph Murray
AMAna M. B. Menezes
Ana M. B. Menezes
LRLuis Augusto Rohde
Luis Augusto Rohde
Attention-deficit/hyperactivity disorder (ADHD) has been traditionally conceptualized as a neurodevelopmental disorder. Most recently, DSM-5 included ADHD in a specific section under this umbrella.1 On the basis solely of clinical wisdom, DSM-III introduced ADHD criterion B, requiring symptoms to be present before the age of 7 years, and DSM-IV-TR added that impairment must also be present by this same age.2,3 A systematic review of the literature4 challenged the utility and validity of this criterion B. The DSM-5 scientific committee decided to change the criterion to require symptoms before 12 years of age based on evidence that this threshold would capture almost every case presented in childhood, without increasing the prevalence rate.1,5 Furthermore, DSM-5 introduced the concept of adulthood ADHD as a disorder that begins in childhood and requires symptoms to be present before 12 years of age.

8 September 2023 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
SCSamuele Cortese
Samuele Cortese
MSMinjin Song
Minjin Song
LFLuis C. Farhat
Luis C. Farhat
DYDong Keon Yon
Dong Keon Yon
Seung Won LeeSeung Won Lee
Seung Won Lee
MSMarco Solm
Marco Solm